Описание
Combined use of carvedilol and lisinopril in heart failure is guideline-recommended but carries additive hypotensive risk, particularly with initiation or dose uptitration.
Механизм
Carvedilol provides alpha-1 and non-selective beta blockade; lisinopril reduces angiotensin II–mediated vasoconstriction. Additive vasodilation and negative inotropy can cause hypotension.
Клиническое значение
The combination is standard-of-care in HFrEF; benefits include mortality reduction; the primary risk is hypotension, dizziness, and fatigue, especially early in therapy.
Тактика ведения
Initiate at lowest doses; uptitrate each agent separately; monitor blood pressure and renal function throughout titration.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.